International consensus is to tailor HbA1c targets
A consensus position statement from the European Association for the Study of Diabetes (EASD) and the American Diabetes Association, presented at the EASD conference in Berlin last week, says that advice must be personalised rather than working on a ‘one size fits all’ basis and avoid setting general HbA1c levels.
However, in the current Australian Diabetes Society position statement, although an individualised approach for each patient is recommended, a general target HbA1c level of <7.0% is set for most patients. This is qualified by the need to set a target within the range of <6–8%, depending on patient specific factors, such as the type of diabetes and its duration, pregnancy, existing medication, cardiovascular disease, risk of hypoglycaemia and comorbidities.
Professor Graham Jones, RCPA representative on the government’s HbA1c expert